Copyright
©The Author(s) 2015.
World J Hepatol. Oct 18, 2015; 7(23): 2474-2481
Published online Oct 18, 2015. doi: 10.4254/wjh.v7.i23.2474
Published online Oct 18, 2015. doi: 10.4254/wjh.v7.i23.2474
Figure 1 Insulin resistance and the development of hepatocellular carcinoma (cited from Eslam et al[16], 2011).
HCC: Hepatocellular carcinoma; HOMA-IR: Homeostasis model of insulin resistance; IRS: Insulin receptor; MAPK: Mitogen-activated protein kinase; IGF1: Insulin like growth factor 1; CTGF: Connective tissue growth factor.
- Citation: Khattab M, Fouad M, Ahmed E. Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma. World J Hepatol 2015; 7(23): 2474-2481
- URL: https://www.wjgnet.com/1948-5182/full/v7/i23/2474.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i23.2474